Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2018-07-04 Regulatory Filings
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Photosoft efficiently destroys ovarian cancer cells in vitro 2 pages 92.0KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 5 July 2018 from Invion Limited regarding research and development progress on their Photosoft[TM] technology for treating ovarian cancer. It details scientific study results, collaboration with a medical research institute, and future plans for preclinical trials. There are no financial statements, regulatory filings, voting results, or management changes. The content is primarily an R&D update and scientific progress announcement aimed at investors and the public. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the nature of the announcement and its focus on research progress rather than financial or governance matters, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2018-07-04 English
Appendix 3B - shares issued upon exercise of options 12 pages 149.5KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, issue price, purpose, and compliance with ASX rules. It also includes calculations related to placement capacity under ASX Listing Rules 7.1 and 7.1A. The document is a formal announcement to the Australian Securities Exchange (ASX) regarding a new issue of shares and related securities. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital raising and share issuance. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement.
2018-05-28 English
Appendix 3B - shares issued on exercise of options 12 pages 152.3KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, exercise prices, shareholder approvals, and compliance with ASX listing rules. It includes sections on placement capacity calculations under ASX rules 7.1 and 7.1A, quotation agreements, and other regulatory compliance details related to new share issues. The document is a formal announcement to the Australian Securities Exchange (ASX) regarding the issuance and quotation of additional shares. This type of document is specifically used to announce new share issues and capital changes, not a full financial report or earnings release. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (15,000 characters) and content confirm it is not a brief announcement of a report (RPA) or a regulatory filing (RNS) but a detailed capital change announcement.
2018-05-21 English
Appendix 3B - issue of shares following options exercise 12 pages 153.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, exercise prices, shareholder approvals, and compliance with ASX rules. It includes sections on placement capacity calculations under ASX Listing Rules 7.1 and 7.1A, which relate to the company's ability to issue new shares without shareholder approval. The document is a formal announcement to the Australian Securities Exchange (ASX) regarding the issuance and quotation of additional securities. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2018-05-13 English
Appendix 3B - issue of shares following options exercise 12 pages 154.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose of the issue, and compliance with ASX rules. It includes sections on placement capacity calculations under ASX Listing Rules 7.1 and 7.1A, which relate to the company's ability to issue new shares without shareholder approval. The document is a formal announcement to the Australian Securities Exchange (ASX) regarding a new share issue and application for quotation of additional securities. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital raising and share issuance. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement.
2018-05-09 English
Appendix 3B - issue of shares following options exercise 13 pages 155.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, issue price, purpose, and compliance with ASX rules. It includes sections on placement capacity calculations under ASX Listing Rules 7.1 and 7.1A, which relate to the company's ability to issue new shares without shareholder approval. The document is a formal announcement to the Australian Securities Exchange (ASX) regarding a new share issue and application for quotation of additional securities. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital raising and share issuance. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement.
2018-04-29 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.